Predictmedix Preps for Big Year Ahead, as Demand for its Contactless Screening Devices sees Ramp Up of Partnerships, M&A and Strategic Financing

Predictmedix is an Artificial Intelligence company that has developed  fast, non-invasive, contactless screening devices that detect  infectious diseases, impairment and even mental illness at any location  where mass amounts of people gather, such as: Hospitals Stadiums Airports Malls Government Buildings Office Complexes These screeners are fully automated and intelligent, so they don’t  need personnel to operate them. They determine the probability of a  person being infected with illnesses such as COVID-19, so safety  protocols can be initiated. Earlier this month, the AI firm penned a major strategic partnership  with Juiceworks and Connectus Global to deploy its Safe Entry Stations  nationwide. That news came during an increasingly busy time for $PMED, which has included: An LOI to acquire AI-powered tech firm Symp2Pass The engagement of investment banking firm Kingswood Capital Markets in preparation for NASDAQ listing Major partnerships Strategic financing developments You’re going to want to get comfy for this chat with Predictmedix COO & Director Rahul Kushwah: